Stool collect

PreclinicalBiologic

AAssistance Publique - Hôpitaux de Paris

Stool collect is one of 234 biologic programs targeting Malnutrition. It is currently in Preclinical.

Indications

Total Trials

Active Trials

233

Competitors

Pipeline

Status by Indication[3][1]

Indication

MalnutritionActive, not recruiting

Bronchopulmonary DysplasiaActive, not recruiting

Anorexia NervosaActive, not recruiting

Alzheimer DiseaseActive, not recruiting

Netherton SyndromeActive, not recruiting

Intestinal NeoplasmActive, not recruiting

GastroenteritisActive, not recruiting

Eosinophilic EsophagitisActive, not recruiting

EndometriosisActive, not recruiting

MalnutritionPreclinical

Active, not recruiting

Bronchopulmonary DysplasiaPreclinical

Active, not recruiting

Anorexia NervosaPreclinical

Active, not recruiting

Alzheimer DiseasePreclinical

Active, not recruiting

Netherton SyndromePreclinical

Active, not recruiting

Intestinal NeoplasmPreclinical

Active, not recruiting

GastroenteritisPreclinical

Active, not recruiting

Eosinophilic EsophagitisPreclinical

Active, not recruiting

EndometriosisPreclinical

Active, not recruiting

Competition

Competitive Landscape

199 competitors in Endometriosis

#DrugCompanyPhaseTrials

Orilissa

AbbVie

Phase 3

16 2

Revia

Teva

Phase 3

1 3

Lupron

EEastern Cooperative Oncology Group

Phase 3

1 4

Trental

VValidus Pharmaceuticals

Phase 3

1 5

Esketamine Hydrochloride

TThe Second Hospital of Anhui Medical University

Phase 3

1 6

Indole-3-Carbinol

UUniversity of Kansas Medical Center

Phase 3

1 7

Add-Back

KKissei Pharmaceutical Co., Ltd.

Phase 3

4 8

Visanne

Bayer

Phase 3

2 9

Triptorelin Acetate PR 1-Month

Ipsen

Phase 3

1 10

BG2109

BBio Genuine (Shanghai) Biotech Co., Ltd.

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Recruiting

Anorexia Nervosa

NCT05632497

Q3 2027

N/ANot yet recruiting

Endometriosis

NCT07078435

Q4 2027

Recruiting

Alzheimer Disease

NCT07118137

Q2 2028

Recruiting

Netherton Syndrome

NCT07280091

Clinical

Trials by Indication[1]

Intestinal Neoplasm1 trial

Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms

Recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT04363983·6,300 enrolled

Bronchopulmonary Dysplasia1 trial

PremaBiom: Metatranscriptomics of the Respiratory Microbiome to Predict the Occurrence of Bronchopulmonary Dysplasia in Preterm Infants

Not yet recruiting·UUniversity Hospital, Caen·N/A·NCT07411261·270 enrolled

Biomarker1 trial

New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome

Recruiting·AAssistance Publique - Hôpitaux de Paris··NCT06694363·14 enrolled

Pathophysiology1 trial

Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura

Completed·—··NCT02317133·100 enrolled

Endometriosis1 trial

Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis

Not yet recruiting·UUniversity Hospital, Grenoble·N/A·NCT07078435·40 enrolled

6 more indications

Gastroenteritis1 trial

Surveillance of Rotavirus Gastroenteritis

Unknown status·—··NCT02900703·9,000 enrolled

Recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT06387030·60 enrolled

Anorexia Nervosa1 trial

Alteration of Symbiosis Intestinal Microbiota on Patients With Anorexia Nervosa

Recruiting·AAssistance Publique - Hôpitaux de Paris··NCT05632497·120 enrolled

Netherton syndrome1 trial

Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome

Recruiting·AAssistance Publique - Hôpitaux de Paris··NCT07280091·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for Stool collect. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Stool collect compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Stool collect. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: AAssistance Publique - Hôpitaux de Paris

Stool collect

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Q3 2027

Q4 2027

Q2 2028

Trials by Indication[1]

Intestinal Neoplasm1 trial

Bronchopulmonary Dysplasia1 trial

Biomarker1 trial

Pathophysiology1 trial

Endometriosis1 trial

Gastroenteritis1 trial

Malnutrition1 trial

Alzheimer disease1 trial

Eosinophilic Esophagitis1 trial

Anorexia Nervosa1 trial

Netherton syndrome1 trial

References

Drug Info

Quick Facts

Related News